Catalyst Funds Management Pty »

Nautilus Biotechnology shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $180k 46k 3.88

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
Vanguard Group
Vanguard Capital Management
Hartland & Co
Comprehensive Financial Management
Amazon
Millennium Management
Clarius
_Sentinel Trust Company, LBA______________
Acadian Asset Management
Tikvah Management
Geode Capital Management

View all funds holding Nautilus Biotechnology